(Q39502629)

12 September 2017

title

Novel peptide targeting integrin αvβ3-rich tumor cells by magnetic resonance imaging (English)

1 reference

12 September 2017

Guoqiu Wu

1

1 reference

12 September 2017

Xiaodong Wang

2

1 reference

12 September 2017

Gang Deng

3

1 reference

12 September 2017

Linyuan Wu

4

1 reference

12 September 2017

Shenghong Ju

5

1 reference

12 September 2017

Gaojun Teng

6

1 reference

12 September 2017

Yuyu Yao

7

1 reference

12 September 2017

Xiyong Wang

8

1 reference

12 September 2017

Naifeng Liu

9

1 reference

12 September 2017

publication date

1 August 2011

1 reference

Journal of Magnetic Resonance Imaging

12 September 2017

published in

1 reference

12 September 2017

volume

34

1 reference

12 September 2017

issue

2

1 reference

12 September 2017

page(s)

395-402

1 reference

describes a project that uses

12 September 2017

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

cites work

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

99mTc-labeled cyclic RGDfK dimer: initial evaluation for SPECT imaging of glioma integrin alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

(68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Ultrasonic analysis of peptide- and antibody-targeted microbubble contrast agents for molecular imaging of alphavbeta3-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Gd-DOTA conjugate of RGD as a potential tumor-targeting MRI contrast agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Preparation of anti-human cardiac troponin I immunomagnetic nanoparticles and biological activity assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

The CCN family: a new stimulus package

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Fisp12/mouse connective tissue growth factor mediates endothelial cell adhesion and migration through integrin alphavbeta3, promotes endothelial cell survival, and induces angiogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Activation-dependent adhesion of human platelets to Cyr61 and Fisp12/mouse connective tissue growth factor is mediated through integrin alpha(IIb)beta(3)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

The angiogenic factors Cyr61 and connective tissue growth factor induce adhesive signaling in primary human skin fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Medical application of functionalized magnetic nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Noninvasively characterizing the different alphavbeta3 expression patterns in lung cancers with RGD-USPIO using a clinical 3.0T MR scanner

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJMRI.22620

21 January 2018

Identifiers

DOI

10.1002/JMRI.22620

1 reference

release_lyi4pqgupffu3dtnfokn75fm6a

12 September 2017

Fatcat ID

0 references

1 reference